of borderline significancep = 0.10
More recently the HPTN-035 trial of 0.5% PRO2000 gel (Endo Pharmaceuticals, Chadds Ford, PA, USA), a viral entry inhibitor, reported an estimated effectiveness of 30% (95% CI [-8%; 54%]) which, although of borderline significance (p = 0.10), was welcomed with optimism [ 3 ].